Apellis Pharmaceuticals, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ABOS
|
Acumen Pharmaceuticals, Inc. | $2.37 | $157.41 M | -2.5 | 51 | $0 |
 AKRO
|
Akero Therapeutics, Inc. | $28.25 | $1.59 B | -7.1 | 61 | $0 |
 AMLX
|
Amylyx Pharmaceuticals, Inc. | $3.14 | $120.37 M | -1.65 | 384 | $380.79 M |
 BPMC
|
Blueprint Medicines Corporation | $88.58 | $6.47 B | -21.48 | 638 | $249.38 M |
 CERE
|
Cerevel Therapeutics Holdings, Inc. | $44.96 | $7.29 B | -14.66 | 355 | $0 |
 DAWN
|
Day One Biopharmaceuticals, Inc. | $14.10 | $1.12 B | -5.11 | 169 | $0 |
 IMVT
|
Immunovant, Inc. | $30.48 | $3.68 B | -13.39 | 207 | $0 |
 INZY
|
Inozyme Pharma, Inc. | $5.17 | $286.39 M | -3.43 | 59 | $0 |
 MDGL
|
Madrigal Pharmaceuticals, Inc. | $208.36 | $5.21 B | -10.55 | 376 | $0 |
 MREO
|
Mereo BioPharma Group plc | $4.40 | $479.72 M | -22.8 | 33 | $10.00 M |
 MRTX
|
Mirati Therapeutics, Inc. | $58.70 | $4.12 B | -4.82 | 587 | $12.44 M |
 RXDX
|
Prometheus Biosciences, Inc. | $199.92 | $9.56 B | -56.47 | 97 | $6.81 M |
 TERN
|
Terns Pharmaceuticals, Inc. | $8.29 | $462.44 M | -5.67 | 66 | $0 |
 XFOR
|
X4 Pharmaceuticals, Inc. | $0.62 | $169.62 M | -1.51 | 127 | $0 |